Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Accelerate Diagnostics, Inc. (AXDX : NSDQ)
 
 • Company Description   
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.

Number of Employees: 220

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.54 Daily Weekly Monthly
20 Day Moving Average: 672,366 shares
Shares Outstanding: 69.66 (millions)
Market Capitalization: $37.87 (millions)
Beta: 1.90
52 Week High: $9.36
52 Week Low: $0.50
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -46.70% -39.97%
12 Week -78.16% -76.00%
Year To Date -89.58% -86.87%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3950 South Country Club Road Suite 470
-
Tucson,AZ 85714
USA		 ph: 520-365-3100
fax: 520-269-6580		 investors@axdx.com http://acceleratediagnostics.com
 
 • General Corporate Information   
Officers
Jack Phillips - President; Chief Executive Officer
John Patience - Chairman
Steve Reichling - Chief Financial Officer
Tom Brown - Director
Louise Francesconi - Director

Peer Information
Accelerate Diagnostics, Inc. (ABMD)
Accelerate Diagnostics, Inc. (DMDS)
Accelerate Diagnostics, Inc. (CPWY.)
Accelerate Diagnostics, Inc. (EQUR)
Accelerate Diagnostics, Inc. (ECIA)
Accelerate Diagnostics, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 00430H102
SIC: 3826
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 69.66
Most Recent Split Date: (:1)
Beta: 1.90
Market Capitalization: $37.87 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.33 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 3.11
EPS Growth
vs. Year Ago Period: 39.02%
vs. Previous Quarter: -8.70%
Sales Growth
vs. Year Ago Period: 17.47%
vs. Previous Quarter: -10.36%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -76.44
12/31/21 - -80.03
09/30/21 - -81.72
Current Ratio
03/31/22 - 7.44
12/31/21 - 10.56
09/30/21 - 9.52
Quick Ratio
03/31/22 - -
12/31/21 - 9.83
09/30/21 - 8.23
Operating Margin
03/31/22 - -515.61
12/31/21 - -598.05
09/30/21 - -639.62
Net Margin
03/31/22 - -555.47
12/31/21 - -661.94
09/30/21 - -639.62
Pre-Tax Margin
03/31/22 - -555.12
12/31/21 - -659.12
09/30/21 - -639.68
Book Value
03/31/22 - -0.82
12/31/21 - -0.57
09/30/21 - -0.65
Inventory Turnover
03/31/22 - 1.70
12/31/21 - 1.42
09/30/21 - 0.78
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©